Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: A4HQL5
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_SKI1_1 | 105 | 109 | PF00082 | 0.327 |
CLV_PCSK_SKI1_1 | 34 | 38 | PF00082 | 0.533 |
CLV_PCSK_SKI1_1 | 46 | 50 | PF00082 | 0.335 |
CLV_PCSK_SKI1_1 | 5 | 9 | PF00082 | 0.673 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.617 |
DOC_CYCLIN_RxL_1 | 2 | 11 | PF00134 | 0.668 |
DOC_USP7_UBL2_3 | 99 | 103 | PF12436 | 0.424 |
DOC_WW_Pin1_4 | 28 | 33 | PF00397 | 0.313 |
DOC_WW_Pin1_4 | 51 | 56 | PF00397 | 0.370 |
LIG_14-3-3_CanoR_1 | 105 | 110 | PF00244 | 0.545 |
LIG_14-3-3_CanoR_1 | 63 | 73 | PF00244 | 0.533 |
LIG_EH1_1 | 94 | 102 | PF00400 | 0.499 |
LIG_FHA_1 | 115 | 121 | PF00498 | 0.391 |
LIG_FHA_1 | 65 | 71 | PF00498 | 0.463 |
LIG_FHA_2 | 113 | 119 | PF00498 | 0.436 |
LIG_NRBOX | 2 | 8 | PF00104 | 0.455 |
LIG_SH2_PTP2 | 106 | 109 | PF00017 | 0.486 |
LIG_SH2_STAT5 | 106 | 109 | PF00017 | 0.440 |
LIG_SH2_STAT5 | 113 | 116 | PF00017 | 0.388 |
LIG_SH2_STAT5 | 83 | 86 | PF00017 | 0.417 |
LIG_SH3_3 | 98 | 104 | PF00018 | 0.458 |
MOD_CDC14_SPxK_1 | 31 | 34 | PF00782 | 0.347 |
MOD_CDK_SPxK_1 | 28 | 34 | PF00069 | 0.328 |
MOD_CK1_1 | 124 | 130 | PF00069 | 0.510 |
MOD_CK2_1 | 112 | 118 | PF00069 | 0.446 |
MOD_GlcNHglycan | 10 | 13 | PF01048 | 0.620 |
MOD_GSK3_1 | 105 | 112 | PF00069 | 0.557 |
MOD_GSK3_1 | 47 | 54 | PF00069 | 0.327 |
MOD_GSK3_1 | 8 | 15 | PF00069 | 0.644 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.712 |
MOD_NEK2_1 | 8 | 13 | PF00069 | 0.508 |
MOD_NEK2_2 | 18 | 23 | PF00069 | 0.602 |
MOD_NEK2_2 | 41 | 46 | PF00069 | 0.401 |
MOD_PIKK_1 | 64 | 70 | PF00454 | 0.482 |
MOD_PKA_2 | 1 | 7 | PF00069 | 0.623 |
MOD_Plk_1 | 18 | 24 | PF00069 | 0.596 |
MOD_Plk_4 | 109 | 115 | PF00069 | 0.502 |
MOD_Plk_4 | 12 | 18 | PF00069 | 0.638 |
MOD_Plk_4 | 124 | 130 | PF00069 | 0.374 |
MOD_ProDKin_1 | 28 | 34 | PF00069 | 0.320 |
MOD_ProDKin_1 | 51 | 57 | PF00069 | 0.372 |
TRG_ENDOCYTIC_2 | 106 | 109 | PF00928 | 0.504 |
TRG_ER_diArg_1 | 71 | 74 | PF00400 | 0.487 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PEU6 | Leptomonas seymouri | 71% | 99% |
A0A0S4KL81 | Bodo saltans | 32% | 100% |
A0A1X0NL52 | Trypanosomatidae | 44% | 100% |
A0A3S5IS15 | Trypanosoma rangeli | 48% | 100% |
A0A3S7XCF1 | Leishmania donovani | 85% | 100% |
A4ICD4 | Leishmania infantum | 85% | 100% |
D0A3R9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 45% | 78% |
E9AUD0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 100% |
Q4Q060 | Leishmania major | 84% | 100% |